Form D · Other Technology
Sound Life Sciences, Inc.
Seattle, WA · CIK 0001773285
Offering snapshot reported Apr 12, 2019 · SEC filing
- Reported sold
- $235K Offering amount: $400K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 3, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2019 | Initial | $235,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-337253
Debt is convertible, under certain circumstances, into issuer equity.
Source: Form D, filed Apr 12, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shyamnath Gollakota | Director, Executive, Promoter |
| Nick Mark | Director |
| Jacob Eugene Sunshine | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
Startup Hall Box 354625 1100 Ne Campus Parkway Ste 200
Seattle, WA, 98105
Seattle, WA, 98105